Giraudo Bryan

CIK 00017408472 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001740847

Recent Transactions

50 trades

Award
Gossamer Bio, Inc.$GOSS
Common Stock
2026-01-02+115,750→ 389,737 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-01-02+3,762→ 3,762 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-01-02+2,695→ 17,825 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2026-01-02+693,750→ 693,750 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2025-10-01+181,250→ 273,987 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2025-03-04+638,000→ 638,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-01-02+5,130→ 15,130 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2025-01-02+6,584→ 6,584 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2024-06-18$0.59/sh+100,000→ 480,010 total
Sale
Gossamer Bio, Inc.$GOSS
Common Stock
2024-03-27$1.16/sh−6,430→ 92,737 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2024-01-02+543,750→ 543,750 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-01-02+25,700→ 25,700 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-11-20+181,250→ 181,250 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2023-11-13$0.56/sh+200,000→ 380,010 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2023-07-24$1.82/sh+54,020→ 180,010 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2023-07-24$0.13/sh+13,505→ 13,505 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05−71,500→ 0 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05+60,000→ 60,000 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05−90,000→ 0 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05+176,667→ 176,667 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05+100,000→ 100,000 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05−265,000→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05−150,000→ 0 total
Disposition to Issuer
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05−145,000→ 0 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05+47,667→ 47,667 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-05-05+96,667→ 96,667 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2023-04-04$1.02/sh+55,000→ 125,990 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2023-03-20+211,500→ 211,500 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2023-03-20$0.97/sh+50,000→ 70,990 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2023-01-16+30,000→ 30,000 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2022-12-07+211,500→ 211,500 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2022-07-15$7.21/sh+13,869→ 20,990 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2022-05-26+20,000→ 20,000 total
Sale
Gossamer Bio, Inc.$GOSS
Common Stock
2022-03-23$8.91/sh−10,722→ 99,167 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2022-01-06+265,000→ 265,000 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2021-09-16+150,000→ 150,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2021-05-27+18,000→ 18,000 total
Sale
Gossamer Bio, Inc.$GOSS
Common Stock
2021-03-23$9.48/sh−5,490→ 109,889 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2021-02-25+45,000→ 115,379 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (Right to Buy)
2021-02-25+90,000→ 90,000 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2020-10-14$10.01/sh+3,000→ 7,121 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2020-06-23$12.96/sh+2,000→ 4,121 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2020-05-28+15,000→ 15,000 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (right to buy)
2020-02-14+71,500→ 71,500 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2020-02-14+46,500→ 70,379 total
Purchase
Protagonist Therapeutics, Inc$PTGX
Common Stock
2019-12-03$5.70/sh+8,000→ 8,000 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2019-09-26$16.78/sh+1,121→ 2,121 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2019-06-07+12,000→ 12,000 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2019-05-30$18.70/sh+1,000→ 1,000 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (right to buy)
2019-03-25+145,000→ 145,000 total

Companies

Recent Filings

Address

C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140

NEWARK, CA, 94560-1160

View on SEC.gov